Sign In
Buy CFMS
$2.26
+0 (+0%)
At Close: Nov 30, 2023
Conformis Announces Return to Work of Furloughed Employees
11:00am, Thursday, 23'rd Apr 2020
Conformis, Inc. (CFMS) announced today that, due in large part to a loan made available to the Company under the Paycheck Protection Program (“PPP Loan”) offered by the U.S. Small Business Adminis
Analysts Anticipate ConforMIS Inc (NASDAQ:CFMS) Will Announce Earnings of -$0.09 Per Share
09:58am, Wednesday, 22'nd Apr 2020
Brokerages expect ConforMIS Inc (NASDAQ:CFMS) to announce ($0.09) earnings per share for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for ConforMIS’s earnings, wit
ConforMIS Inc (NASDAQ:CFMS) Expected to Announce Quarterly Sales of $18.95 Million
07:46am, Tuesday, 21'st Apr 2020
Wall Street analysts expect ConforMIS Inc (NASDAQ:CFMS) to announce sales of $18.95 million for the current quarter, Zacks reports. Two analysts have issued estimates for ConforMIS’s earnings, with
Conformis Receives $4.7 Million under the Paycheck Protection Program
01:00pm, Monday, 20'th Apr 2020
Conformis, Inc. (CFMS) today announced that on April 17, 2020 the Company entered into a $4,719,800 promissory note with East West Bank (EWBC) under the Paycheck Protection Program (“PPP”) offered
ConforMIS Inc (NASDAQ:CFMS) Receives Consensus Rating of "Hold" from Analysts
10:32am, Saturday, 18'th Apr 2020
ConforMIS Inc (NASDAQ:CFMS) has earned an average recommendation of “Hold” from the six brokerages that are covering the company, MarketBeat.com reports. One equities research analyst has rated th
Conformis to Hold Virtual Annual Meeting of Stockholders on April 27, 2020
08:45pm, Thursday, 09'th Apr 2020
Conformis, Inc. (CFMS) today announced that, due to the public health impact of the novel coronavirus outbreak and governmental restrictions limiting the number of people who may gather together, and
Zacks.com featured highlights include: Amphastar Pharmaceuticals, ConforMIS, Kirkland Lake Gold, Cubic and Cimpress
01:33pm, Wednesday, 25'th Mar 2020
Zacks.com featured highlights include: Amphastar Pharmaceuticals, ConforMIS, Kirkland Lake Gold, Cubic and Cimpress
ConforMIS (CFMS) Gets a Hold Rating from BTIG
05:27pm, Tuesday, 24'th Mar 2020
BTIG analyst Ryan Zimmerman maintained a Hold rating on ConforMIS (CFMS – Research Report) yesterday. The company’s shares closed last
What Bargain Hunting? Tap 5 Stocks With Rising P/E
01:47pm, Tuesday, 24'th Mar 2020
Bet on these top-ranked stocks with rising P/E to realize outsized gains.
ConforMIS (CFMS) Receives a Buy from Oppenheimer
10:01am, Tuesday, 24'th Mar 2020
Oppenheimer analyst Steven Lichtman maintained a Buy rating on ConforMIS (CFMS – Research Report) today. The company’s shares closed last
Conformis Announces Actions to Mitigate COVID-19 Impact
11:44am, Monday, 23'rd Mar 2020
Conformis, Inc. (CFMS), an orthopedic arthroplasty medical technology company, today announced proactive steps it is taking and planning to mitigate the negative financial and operational impacts of t
Edited Transcript of CFMS earnings conference call or presentation 2-Mar-20 9:30pm GMT
11:42pm, Friday, 20'th Mar 2020
Q4 2019 Conformis Inc Earnings Call
Oppenheimer Maintains Their Buy Rating on ConforMIS (CFMS)
12:03pm, Tuesday, 03'rd Mar 2020
Oppenheimer analyst Steven Lichtman maintained a Buy rating on ConforMIS (CFMS – Research Report) today and set a price target
Analysts Are Bullish on These Healthcare Stocks: Intra-Cellular Therapies (ITCI), Kaleido Biosciences (KLDO)
11:07am, Tuesday, 03'rd Mar 2020
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Intra-Cellular Therapies (
ITCI
–
Research Report
), Kaleido Biosciences (
KLDO
–
Research Report
)
Conformis Reports Fourth Quarter and Year End 2019 Financial Results
10:45pm, Monday, 02'nd Mar 2020
BILLERICA, Mass., March 02, 2020 -- Conformis, Inc. (NASDAQ:CFMS), announced today financial results for the fourth quarter and year ended December 31, 2019. Q4 Summary Total.
